Clinical Trials in Ohio

Showing 16721-16740 of 20,938 trials

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

NCT00269477

The study is designed to evaluate the persistence of bactericidal antibodies in subjects aged 15 to 23 years (not yet 24 years) who had been vaccinated five years previously in Study MTA02 and did not participate in Study MTA19 (NCT 00777790). In addition, the kinetics of the antibody response will be evaluated in a subset of these participants who will receive a booster dose of Menactra® vaccine. This will be compared to aged matched control subjects who have not been previously vaccinated with a meningococcal vaccine or had documented meningitis disease who will also receive a dose of Menactra® vaccine.

MeningitisMeningococcal Infection

Sanofi Pasteur, a Sanofi Company145 participantsStarted Dec 2005

Atlanta, Georgia, United States • Marietta, Georgia, United States • Woburn, Massachusetts, United States +5 more locations

COMPLETED32 miles

Validation of TearLab Osmometer - Human Factor Usability Report

NCT00731484

The objective of this study is to validate the performance of the OcuSense TearLab™ osmolarity test when performed in physician office laboratories (POL) by health care professionals using human tear fluid collected from volunteer subjects and contrived tear samples.

Dry Eye Syndromes

TearLab Corporation233 participantsStarted Jul 2008

San Diego, California, United States • Louisville, Kentucky, United States • Columbus, Ohio, United States

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

Validation of TearLab Osmometer - Human Factor Usability Report

Find Trials by Condition in Ohio

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Dose Comparison Study of Menactra® in US Children

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

Health-related Quality of Life Measure in Pediatric Lupus

ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects

VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis

Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®

Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care

Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td

Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Safety and Efficacy Study of Topography-Guided LASIK to Treat Myopia and Hyperopia

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Characterization of Adipose Derived Regenerative Cells (ADRCs) From Patients With Chronic Heart Disease

Water-aided Colonoscopy vs Air Insufflation Colonoscopy in Colorectal Cancer Screening